Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes - Storey,R.F.; Oldroyd,K.G.; Wilcox,R.G. (Thromb Haemost, 2001)